SREBF2 and metabolic dysfunction-associated steatohepatitis: Mechanistic studies reveal MST1 deficiency promotes SREBP2 nuclear localization, upregulates cholesterologenic enzymes, exacerbates hepatocellular cholesterol overload, and intensifies NASH-associated hepatic injury and fibrogenesis.